Cannabis Could Be a $15 Billion Business This Year — And That’s Just the Legal Stuff

By Hristina Byrnes Updated Jan 6, 3:30AM EST · Published Jun 24, 9:56AM EDT

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Cannabis Could Be a $15 Billion Business This Year — And That’s Just the Legal Stuff — © OpenRangeStock / Getty Images

Global legal cannabis sales are predicted to reach $14.9 billion in 2019, a 36% increase over last year, according to the 2019 edition of the annual “State of Legal Cannabis Markets” report.

A joint study by the market research department of the cannabis investment company Arcview Group and the cannabis data firm BDS Analytics, the 2019 report — which runs more than 350 pages and sells for $697 per copy — is now in its seventh year.

The 2019 report is the first to evaluate the “Total Cannabinoid Market.” That means that it includes data not just on medical and recreational cannabis (including edibles) sold at dispensaries but also non-psychoactive CBD products and CBD-based pharmaceuticals approved by the Food and Drug Administration (FDA).

While $14.9 billion might seem like a substantial figure, illicit pot sales continue to far outpace the legal market. Californians alone spent an estimated $3.7 billion on illegal pot last year — more than four times what they bought legally. And while legal cannabis accounted for $1.2 billion in sales in Canada for the last quarter of 2018 — following legalization — illegal sales for the same period were estimated at $4.7 billion.

Projections for the year were boosted by the launch of legal recreational cannabis sales in Canada last October and by the proliferation of CBD products. Canada, it might be noted, is home to seven of North America’s 10 largest marijuana companies.

Contact [email protected] for any questions or corrections.

Disclaimer: Energy Exploration Technologies, Inc. ("EnergyX") has engaged 24/7 Wall St to publish this communication in connection with EnergyX's ongoing Regulation A offering. 24/7 Wall St has been paid in cash and may receive additional compensation. 24/7 Wall St and/or its affiliates do not currently hold securities of EnergyX.

This compensation and any current or future ownership interest could create a conflict of interest. Please consider this disclosure alongside EnergyX's offering materials. EnergyX's Regulation A offering has been qualified by the SEC. Offers and sales may be made only by means of the qualified offering circular. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at invest.energyx.com/.

Comparisons to other companies are for informational purposes only and should not imply similar results. Past performance is not indicative of future results. Market shortfall are forward‑looking estimates and are subject to substantial uncertainty. Investments in private placements, and start-up investments in particular, are long-term, illiquid, speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups

Follow 24/7 Wall St. on Google

About the Author Hristina Byrnes →

Hristina Byrnes is the editor of 247Tempo.com, where she handles the site's assignments and editing. She holds a master's degree in journalism from Columbia University, which she earned in 2012, and she specializes in translating complex health data research into engaging, accessible stories for a general audience.

When she's not poring over the latest data sets or brainstorming story ideas, you can find Hristina watching tennis, playing tennis with her son, or trying to get her daughter into tennis.